Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5267513
Max Phase: Preclinical
Molecular Formula: C38H52O4
Molecular Weight: 572.83
Associated Items:
ID: ALA5267513
Max Phase: Preclinical
Molecular Formula: C38H52O4
Molecular Weight: 572.83
Associated Items:
Canonical SMILES: C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC=C(c6ccc(C(=O)OC)cc6)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12
Standard InChI: InChI=1S/C38H52O4/c1-23(2)26-15-20-38(33(40)41)22-21-36(6)28(31(26)38)13-14-30-35(5)18-16-27(24-9-11-25(12-10-24)32(39)42-8)34(3,4)29(35)17-19-37(30,36)7/h9-12,16,26,28-31H,1,13-15,17-22H2,2-8H3,(H,40,41)/t26-,28+,29-,30+,31+,35-,36+,37+,38-/m0/s1
Standard InChI Key: PXMFCLBKEMWWCH-TVJWCRJGSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 572.83 | Molecular Weight (Monoisotopic): 572.3866 | AlogP: 9.21 | #Rotatable Bonds: 4 |
Polar Surface Area: 63.60 | Molecular Species: ACID | HBA: 3 | HBD: 1 |
#RO5 Violations: 2 | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 4.78 | CX Basic pKa: | CX LogP: 9.03 | CX LogD: 6.45 |
Aromatic Rings: 1 | Heavy Atoms: 42 | QED Weighted: 0.29 | Np Likeness Score: 2.27 |
1. Borková L, Frydrych I, Vránová B, Jakubcová N, Lišková B, Gurská S, Džubák P, Pavliš P, Hajdúch M, Urban M.. (2022) Lupane derivatives containing various aryl substituents in the position 3 have selective cytostatic effect in leukemic cancer cells including resistant phenotypes., 244 [PMID:36283179] [10.1016/j.ejmech.2022.114850] |
Source(1):